This model allowed robust in vivo testing of ferroptosis induction: we obtained remarkable tumor remission in high MYCN neuroblastoma by combining inhibition of (1) cystine import using IKE and (2) transsulfuration using PPG together with (3) CRISPR–Cas9-mediated GPX4 deletion. The gene discussed is GPX4; the disease is neuroblastoma.